GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abera Bioscience AB (XSAT:ABERA) » Definitions » Cash per Share

Abera Bioscience AB (XSAT:ABERA) Cash per Share : kr0.17 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Abera Bioscience AB Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Abera Bioscience AB's Cash per Share for the quarter that ended in Jun. 2024 was kr0.17.


Abera Bioscience AB Cash per Share Historical Data

The historical data trend for Abera Bioscience AB's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abera Bioscience AB Cash per Share Chart

Abera Bioscience AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial 0.25 0.09 1.03 1.20 0.23

Abera Bioscience AB Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.13 0.23 0.46 0.17

Abera Bioscience AB Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Abera Bioscience AB's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Abera Bioscience AB's Cash per Share for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abera Bioscience AB  (XSAT:ABERA) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Abera Bioscience AB Cash per Share Related Terms

Thank you for viewing the detailed overview of Abera Bioscience AB's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abera Bioscience AB Business Description

Traded in Other Exchanges
N/A
Address
Svetsarvagen 15, Solna, SWE, SE-17141
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.

Abera Bioscience AB Headlines

No Headlines